Chenye Zhao

Xi'an, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

CHTOP regulates the NRF2/HO-1 axis to modulate chemoresistance in colorectal cancer.

CHTOP regulates the NRF2/HO-1 axis to modulate chemoresistance in colorectal cancer.

Journal: Redox biology
Published: July 25, 2026

ZIC5, a survival biomarker, facilitates tumor progression and stemness in colon cancer via the activation of the Wnt signaling pathway.

ZIC5, a survival biomarker, facilitates tumor progression and stemness in colon cancer via the activation of the Wnt signaling pathway.

Journal: Scientific reports
Published: April 09, 2025

FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis.

FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis.

Journal: Molecular medicine (Cambridge, Mass.)
Published: October 07, 2024

Identification of MAPK12 as a Prognostic Biomarker for Esophageal Carcinoma Using Bioinformatics and Machine Learning.

Identification of MAPK12 as a Prognostic Biomarker for Esophageal Carcinoma Using Bioinformatics and Machine Learning.

Journal: BioMed research international
Published: September 24, 2024

Dual-wavelength (980/1470 nm) laser incisions in porcine colon tissue: a histological in vitro study.

Dual-wavelength (980/1470 nm) laser incisions in porcine colon tissue: a histological in vitro study.

Journal: Lasers in medical science
Published: September 21, 2024

Clinical significance of the modified Naples prognostic score in patients with stage II-III colon cancer undergoing curative resection: a retrospective study from the real world.

Clinical significance of the modified Naples prognostic score in patients with stage II-III colon cancer undergoing curative resection: a retrospective study from the real world.

Journal: Frontiers in oncology
Published: April 03, 2024

USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis.

USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis.

Journal: Frontiers in immunology
Published: October 22, 2023

FXR controls duodenogastric reflux-induced gastric inflammation through negatively regulating ER stress-associated TNXIP/NLPR3 inflammasome.

FXR controls duodenogastric reflux-induced gastric inflammation through negatively regulating ER stress-associated TNXIP/NLPR3 inflammasome.

Journal: iScience
Published: February 22, 2023

3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.

3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.

Journal: Cancer gene therapy
Published: February 02, 2023

USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.

USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.

Journal: Cell death and differentiation
Published: January 13, 2023

A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer.

A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer.

Journal: Epigenomics
Published: December 22, 2022

DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.

DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.

Journal: Cell cycle (Georgetown, Tex.)
Published: August 04, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026